Baxter International Inc. Files 8-K

Ticker: BAX · Form: 8-K · Filed: Mar 14, 2025 · CIK: 10456

Sentiment: neutral

Topics: disclosure, financial-statements, debt

Related Tickers: BAX

TL;DR

BAX filed an 8-K on 3/14/25 covering financial statements and debt notes.

AI Summary

Baxter International Inc. filed an 8-K on March 14, 2025, reporting on Regulation FD disclosures and financial statements. The filing includes details about their common stock and global notes due in 2025 and 2029. Baxter International Inc. is incorporated in Delaware and has its principal executive offices in Deerfield, Illinois.

Why It Matters

This filing provides an update on Baxter International's corporate and financial reporting, which is important for investors to stay informed about the company's status and any material events.

Risk Assessment

Risk Level: low — This is a routine filing of financial statements and disclosures, not indicating any immediate operational or financial distress.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on Regulation FD disclosures and to provide financial statements and exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on March 14, 2025.

In which state is Baxter International Inc. incorporated?

Baxter International Inc. is incorporated in Delaware.

What are the maturity dates for the Global Notes mentioned in the filing?

The filing mentions Global Notes due in 2025 and Global Notes due in 2029.

What is the SIC code for Baxter International Inc.?

The Standard Industrial Classification (SIC) code for Baxter International Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 14, 2025 regarding BAXTER INTERNATIONAL INC (BAX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing